Treatment of ventricular tachycardia in an infant.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000790:Angiocardiography; D006328:Cardiac Catheterization; D002648:Child; D002675:Child, Preschool; D004077:Digoxin / Q000009:adverse effects; D004357:Drug Synergism; D004554:Electric Countershock; D004562:Electrocardiography; D005260:Female; D006352:Heart Ventricles; D006801:Humans; D007223:Infant; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D011342:Procainamide / Q000008:administration & dosage / Q000627:therapeutic use*; D011802:Quinidine / Q000008:administration & dosage / Q000627:therapeutic use*; D013610:Tachycardia / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000209:etiology
D004077:Digoxin; D008012:Lidocaine; D011802:Quinidine; D011342:Procainamide